Topic
biotechnology
Scientists Use AI and Quantum Computing to Generate New Peptides in Spare Time
Researchers at the Technical University of Denmark used a hybrid AI-quantum computing system to generate novel peptides, achieving better results than classical models especially with limited data. The work, done on weekends with leftover funds, could accelerate personalized immunotherapies and vaccines.
TNAU patents high-yield eco-friendly cadambine extraction method from Kadamba tree
Tamil Nadu Agricultural University (TNAU) has secured a patent for a novel method to isolate and quantify cadambine from the Kadamba tree. The process delivers a 93-94% recovery yield while significantly reducing solvent consumption, waste generation, and processing time.
Technology A Startup Is Using Special Polymers to Better Help Nerves Heal
Tissium, a French startup, has developed a biodegradable polymer liquid that attaches to nerve tissue when exposed to light, acting as a splint to hold severed nerves in place. In a US trial of 12 patients with finger nerve injuries, all regained sensation, compared to roughly 80% with standard methods. The company has raised €60 million to commercialize the product and expand to hernia and cardiovascular applications.
Lessons from the Green Revolution: India's Bio Revolution Must Avoid Past Mistakes on Quality and Balance
India's Green Revolution achieved food security but caused soil degradation due to imbalanced fertiliser use. As the country embraces a Bio Revolution with biological inputs, the article warns against repeating past errors, emphasising quality assurance and stewardship.
British Space Startup Mass Balance Launches Autonomous Longevity Lab Into Orbit on SpaceX
British startup Mass Balance launched a self-run chemical laboratory into orbit on a SpaceX transporter to study disease-causing proteins under microgravity. The grapefruit-sized pod will autonomously measure cell behavior and beam data back to Earth, aiming to generate training data for AI models like AlphaFold to improve predictions for age-related diseases.
CRC-Screen: Certified DNA-Synthesis Hazard Screening Under Taxonomic Shift Published on arXiv
A new paper on arXiv presents CRC-Screen, a certified hazard screening method for DNA-synthesis orders. The approach fuses three signals under Conformal Risk Control to maintain a provable bound on expected false-negative rate even when hazardous sequences come from taxonomic families absent from the reference set. Empirical results show 0% test miss rate across folds and 0% false-flag rate on nine of ten taxonomic holdout folds.